EXACT SCIENCES CORP Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-11-05: Form 8-K; Period of report 2024-11-05; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2024-07-31: Form 8-K; Period of report 2024-07-31; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2024-06-17: Form 8-K; Period of report 2024-06-13; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
- 2024-06-03: Form 8-K; Period of report 2024-05-30; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2024-11-05 | 8-K | 2024-11-05 | 2.02 Results of Operations and Financial Condition | 2.02 On November 5, 2024, Exact Sciences Corporation (the "Company") announced its financial results for the quarter ended September 30, 2024. | exas-20241105.htm |
| 2024-07-31 | 8-K | 2024-07-31 | 2.02 Results of Operations and Financial Condition | 2.02 On July 31, 2024, Exact Sciences Corporation (the "Company") announced its financial results for the quarter ended June 30, 2024. | exas-20240731.htm |
| 2024-06-17 | 8-K | 2024-06-13 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 On June 13, 2024, Exact Sciences Corporation (the “Company”) held its 2024 Annual Meeting of Shareholders (the “2024 Annual Meeting”). | exas-20240613.htm |
| 2024-06-03 | 8-K | 2024-05-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | 5.02 On June 3, 2024, Exact Sciences Corporation (the "Company" or "Exact Sciences") announced leadership updates as it prepares for an exciting period of growth and the launches of new breakthrough cancer tests to improve the lives of people around the world. | exas-20240530.htm |
| 2024-05-08 | 8-K | 2024-05-08 | 8.01 Other Events | 8.01 On May 8, 2024, Exact Sciences Corporation (the “Company”) filed with the Securities and Exchange Commission, a prospectus supplement dated May 8, 2024 (the “Prospectus Supplement”) to the Company's automatic shelf registration statement on Form S-3 (Registration No. 333-272196). | exas-20240508.htm |
| 2024-05-08 | 8-K | 2024-05-08 | 2.02 Results of Operations and Financial Condition | 2.02 On May 8, 2024, Exact Sciences Corporation (the "Company") announced its financial results for the quarter ended March 31, 2024. | exas-20240508.htm |
| 2024-04-25 | 8-K | 2024-04-25 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Dr. Freda Lewis-Hall, a member of the Board of Directors (the “Board”) of Exact Sciences Corporation (the “Company”) whose term expires at the 2026 annual meeting of shareholders, has informed the Board that she expects to retire from the Board for personal reasons immediately following the Company’s 2024 annual meeting of shareholders. | exas-20240425.htm |
| 2024-04-17 | 8-K | 2024-04-17 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events | 1.01 On April 17, 2024, Exact Sciences Corporation (the “Company”) completed the closing of the transactions contemplated by those exchange and purchase agreements dated April 10, 2024 (the “Agreements”) entered into with certain holders (the “Holders”) of the Company’s 0.375% Convertible Senior Notes due 2028 (the “2028 Notes”). 2.03 The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. 3.02 The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. 8.01 The Company issued a press release dated April 11, 2024 announcing the transactions described herein. | exas-20240417.htm |
| 2024-04-15 | 8-K | 2024-04-15 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | exas-20240415.htm | |
| 2024-02-21 | 8-K | 2024-02-21 | 2.02 Results of Operations and Financial Condition | exas-20240221.htm | |
| 2024-01-08 | 8-K | 2024-01-07 | 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | exas-20240107.htm |